PATRICK R. O'NEIL, the EVP CLO & General Counsel of $IONS, sold 65,475 shares of the company on 09-03-2025 for an estimated $3,986,772. We received data on the trade from a recent SEC filing. This was a sale of approximately 92.0% of their shares of this class of stock. Following this trade, they now own 5,655 shares of this class of $IONS stock.
$IONS Insider Trading Activity
$IONS insiders have traded $IONS stock on the open market 21 times in the past 6 months. Of those trades, 1 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $IONS stock by insiders over the last 6 months:
- PATRICK R. O'NEIL (EVP CLO & General Counsel) has made 0 purchases and 3 sales selling 89,900 shares for an estimated $5,396,843.
- C FRANK BENNETT (EVP, Chief Scientific Officer) has made 0 purchases and 3 sales selling 48,909 shares for an estimated $2,741,039.
- EUGENE SCHNEIDER (EVP, Chf Clinical Develop Ofcr) has made 0 purchases and 3 sales selling 29,207 shares for an estimated $1,604,121.
- JOSEPH LOSCALZO sold 16,000 shares for an estimated $962,371
- MICHAEL R HAYDEN purchased 15,000 shares for an estimated $477,900
- RICHARD S GEARY (EVP, Chief Development Officer) sold 10,000 shares for an estimated $428,593
- B LYNNE PARSHALL has made 0 purchases and 2 sales selling 5,000 shares for an estimated $209,646.
- BRETT P MONIA (Chief Executive Officer) has made 0 purchases and 3 sales selling 3,732 shares for an estimated $162,380.
- JOSEPH BAROLDI (EVP, Chief Business Officer) sold 3,928 shares for an estimated $111,555
- KYLE JENNE (EVP, Chf GL Pdt Str Ofcr) sold 3,016 shares for an estimated $85,533
- ALLENE M. DIAZ sold 1,427 shares for an estimated $60,687
- BRIAN BIRCHLER (EVP, Corp and Development Ops) sold 680 shares for an estimated $19,291
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IONS Hedge Fund Activity
We have seen 200 institutional investors add shares of $IONS stock to their portfolio, and 208 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 2,724,400 shares (+253.3%) to their portfolio in Q2 2025, for an estimated $107,641,044
- ORBIMED ADVISORS LLC removed 2,540,136 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $100,360,773
- WELLINGTON MANAGEMENT GROUP LLP removed 2,070,645 shares (-24.6%) from their portfolio in Q2 2025, for an estimated $81,811,183
- MILLENNIUM MANAGEMENT LLC added 2,014,157 shares (+317.0%) to their portfolio in Q2 2025, for an estimated $79,579,343
- CITADEL ADVISORS LLC removed 1,985,081 shares (-57.0%) from their portfolio in Q2 2025, for an estimated $78,430,550
- CLEARBRIDGE INVESTMENTS, LLC removed 1,618,220 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $48,821,697
- NORGES BANK removed 1,264,508 shares (-73.7%) from their portfolio in Q2 2025, for an estimated $49,960,711
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IONS Analyst Ratings
Wall Street analysts have issued reports on $IONS in the last several months. We have seen 9 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 09/03/2025
- Goldman Sachs issued a "Sell" rating on 09/03/2025
- BMO Capital issued a "Outperform" rating on 09/03/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/02/2025
- Jefferies issued a "Buy" rating on 09/02/2025
- Needham issued a "Buy" rating on 09/02/2025
- Morgan Stanley issued a "Overweight" rating on 07/31/2025
To track analyst ratings and price targets for $IONS, check out Quiver Quantitative's $IONS forecast page.
$IONS Price Targets
Multiple analysts have issued price targets for $IONS recently. We have seen 17 analysts offer price targets for $IONS in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Luca Issi from RBC Capital set a target price of $80.0 on 09/04/2025
- Kostas Biliouris from BMO Capital set a target price of $70.0 on 09/03/2025
- Gena Wang from Barclays set a target price of $78.0 on 09/03/2025
- Salveen Richter from Goldman Sachs set a target price of $45.0 on 09/03/2025
- David Lebowitz from Citigroup set a target price of $84.0 on 09/03/2025
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $95.0 on 09/02/2025
- Joseph Stringer from Needham set a target price of $70.0 on 09/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
